High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples